| 000 | 01081nam a22003137a 4500 | ||
|---|---|---|---|
| 001 | D0001B000131 | ||
| 003 | DOH | ||
| 005 | 20201218140913.0 | ||
| 008 | 201218b ||||| |||| 00| 0 eng d | ||
| 020 | _a9789241209571 | ||
| 022 | _20512-3054 | ||
| 040 | _erda | ||
| 110 | 2 | _aWorld Health Organization | |
| 245 | 1 | 0 |
_aWHO Expert Committee on specifications for pharmaceutical preparations : _bforty-fourth report |
| 246 | 3 | _aForty-fourth report of the WHO Expert Committee on specifications for pharmaceutical preparations | |
| 260 |
_aGeneva : _bWHO, _c2010. |
||
| 300 | _a276 pages. | ||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarier _avolume |
||
| 490 |
_aWHO technical report series ; _v957 |
||
| 650 | 2 |
_aPharmaceutical Preparations _xstandards |
|
| 650 | 2 |
_aDrug Industry _xlegislation |
|
| 650 | 2 | _aTechnology, Pharmaceutical | |
| 650 | 2 | _aDrug Industry | |
| 650 | 2 | _aQuality Control | |
| 856 | _uhttps://apps.who.int/iris/bitstream/handle/10665/44291/WHO_TRS_957_eng.pdf?sequence=1&isAllowed=y | ||
| 942 |
_2nlm _cBK |
||
| 999 |
_c2131 _d2131 |
||